Nutra Pharma CorpOTC Pink - Current Information:NPHC
- LAST PRICE0.0002
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0002
- Day Range---
- 52 Week Range
- Volume50
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nutra Pharma Corp | 1.5M | 0.3x | --- |
Sangui Biotech International Inc | 1.3M | -126.8x | --- |
CTT Pharmaceutical Holdings Inc | 1.5M | -0.4x | --- |
BiondVax Pharmaceuticals Ltd | 4.9M | -0.5x | --- |
Panbela Therapeutics Inc | 1.7M | 0.0x | --- |
Cell MedX Corp | 1.8M | -2.0x | --- |
Company Information
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer product, Nyloxin, an over-the-counter pain reliever that is a stronger version of Cobroxin and is designed to treat severe chronic pain. Its Pet Pain-Away is an over-the-counter pain reliever designed to treat pain in cats and dogs. Its Equine Pain-Away is an over-the-counter topical pain reliever designed to treat pain in horses. Its Luxury Feet is an over-the-counter pain reliever and anti-inflammatory product, which is designed for women who experience pain or discomfort due to high heels and stilettos. It also manufactures a zeolite detoxifier, Cell Defender for a third-party distributor.
Contact Information
- Headquarters
- 12538 W. Atlantic Blvd.CORAL SPRINGS, FL, United States 33071
- Phone
- 954-509-0911
- Fax
- 877-895-5647
Executives
- Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
- Rik Deitsch
- Chief Scientific Officer
- Dale Vanderputten
- Director
- Stewart Lonky
- Director
- Garry Pottruck
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5M |
|---|---|
Revenue (TTM) | $247.8K |
Shares Outstanding | 7.6B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 0.3x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | 0.2x |
Operating Margin | -592.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
